---
$id: https://graph.org.ai/products/commodity/51161544
$type: Product
source: UNSPSC
code: "51161544"
title: "Lomifylline"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Lomifylline

**UNSPSC Code**: 51161544
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C13H18N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NA91GV8GDJ, chemically known as 1,2,3,6-tetrahydro-1,3-dimethyl-7-(5-oxohexyl)purin-2,6-dion but generally known as lomifylline, which bears US NIH Compound Identifier 65599. European Medicines Agency schedules Lomifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08566MIG. The term LOMIFYLLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). LOMIFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lomifylline under HS 29395900 and SITC 54145. As of Q4 2014, LOMIFYLLINE remains the US FDA Preferred Term for this commodity. Lomifylline bears US NLM identifiers UMLS ID C0614278 and NCI Concept Code C66030. SMILES: O=C1N(C(=O)N(C2NCN(CCCCC(=O)C)C12)C)C.

